HRTX
Heron Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.34
+4.21%Leverage
- Debt / equity
- 21.48x
- Net debt / equity
- 18.48x
- Debt / assets
- 0.59x
- Debt / EBITDA
- -5.33x
- Net debt / EBITDA
- -4.58x
Liquidity & coverage
- Current ratio
- 2.49x
- Quick ratio
- 1.51x
- Cash ratio
- 0.46x
- Interest coverage
- -2.79x
- EBITDA / interest
- -7.14x
- Working capital
- $137.7M
Cash & dividend
- FCF / debt
- -0.08x
- Cash flow / debt
- -0.08x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026